{
    "nctId": "NCT00904410",
    "briefTitle": "Early Assessment of the Response to Neo-adjuvant Chemotherapy in Breast Cancer Patients With FDG-PET",
    "officialTitle": "Early Assessment of the Response to Neo-adjuvant Chemotherapy in Breast Cancer Patients With FDG-PET",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE4",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 63,
    "primaryOutcomeMeasure": "Variation rate of SUV(BSA max)before and after the 1st cycle of neoadjuvant chemotherapy",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Age \\> 18\n* Breast cancer treated by neo-adjuvant chemotherapy (T\\>2cm)\n* Measurable lesions ,assessed clinically and by ultrasound\n* Delay minimum between biopsy and PET: 15 days\n* PS-WHO: 0\n\nExclusion Criteria:\n\n* T\\<2cm\n* Inflammatory breast cancer (T4d)\n* Diabetic patients unbalanced (glycemia\\>1.40)\n* Pregnant or lactating women",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}